| Date Initiated by Firm | November 13, 2020 |
| Create Date | December 08, 2020 |
| Recall Status1 |
Terminated 3 on April 01, 2021 |
| Recall Number | Z-0547-2021 |
| Recall Event ID |
86827 |
| 510(K)Number | K162200 |
| Product Classification |
Photometric method, magnesium - Product Code JGJ
|
| Product | Randox Rx Series Mg - Product Usage: For the quantitative in vitro determination of Magnesium in serum, plasma and urine
Catalogue Number: MG8326 |
| Code Information |
Lot Number: 539770 Exp. Date : 28 March 2022 UDI: 05055273209303 |
Recalling Firm/ Manufacturer |
Randox Laboratories Ltd. 55 Diamond Road Crumlin (North) Ireland
|
Manufacturer Reason for Recall | Failing to meet the linearity performance claims
quoted on the kit inserts-The linearity is reduced by approximately -30% for Serum/ Plasma and -50% for Urine |
FDA Determined Cause 2 | Under Investigation by firm |
| Action | Randox issued Urgent Medical Device Correction letter via e-mail to US Customers on 13 November 2020 stating reason for recall, health risk and action to take:
Discontinue use of and discard any of the above immediately.
" Review your reagent inventory of these products and assess your laboratories needs for reimbursement for discarded inventory.
" Review results generated with the affected batches in line with the clinical profile of the patient.
" Discuss the contents of this notice with your Medical Director.
" Complete and return the response form 12187-QA to technical. services@randox.com within five working days.
Questions or concerns, please contact Randox Technical Services. |
| Quantity in Commerce | 4 kits |
| Distribution | US Nationwide distribution in the states of GA, NJ. |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = JGJ
|